Omnimmune Holdings, Inc.
OMMH
$0.00
$0.000.00%
OTC PK
| 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | 09/30/2009 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -43.98% | -18.89% | -18.06% | -7.51% | -54.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -43.98% | 12.34% | -18.06% | -7.51% | -54.69% |
| Operating Income | 43.98% | -12.34% | 18.06% | 7.51% | 54.69% |
| Income Before Tax | 34.34% | 93.99% | -164.61% | 5.85% | 54.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.34% | 93.99% | -164.61% | 5.85% | 54.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.34% | 93.99% | -164.61% | 5.85% | 54.41% |
| EBIT | 43.98% | -12.34% | 18.06% | 7.51% | 54.69% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 37.09% | 94.05% | -161.77% | 6.50% | 62.62% |
| Normalized Basic EPS | 37.31% | -13.23% | -29.48% | 6.09% | 62.24% |
| EPS Diluted | 37.09% | 94.05% | -161.77% | 6.50% | 62.62% |
| Normalized Diluted EPS | 37.31% | -13.23% | -29.48% | 6.09% | 62.24% |
| Average Basic Shares Outstanding | 4.54% | 1.13% | 1.13% | 0.79% | 21.87% |
| Average Diluted Shares Outstanding | 4.54% | 1.13% | 1.13% | 0.79% | 21.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |